I have been researching CPHI and it does have impressive revenue growth and good products. There are a few things I do not understand is the huge change in number of authorized shares year over year, are earning estimates based on the new shares or old shares, and why they show there cash position under a million, but show over 14 million in working capital cash. The last one is especially odd. Any comments on there three items?
AOB in new on the radar screen for many investors looking to get in to the China market, look for it to overshoot its logical value.
rise in shares was due to IPO and earning estimates are for new total of shares aabout 35 million I think is the new total from under 5 million before the public offering. Not sure on the 3rd question but maybe someone else does. GL